A new treatment approach for lung cancer that resists current therapies
Hi-jacking the kynurenine pathway: A new therapeutic approach used to treat cisplatin resistant lung cancer that evades immune surveillance and proliferates with increased ROS levels
This study is looking at a new way to help people with non-small cell lung cancer that doesn't get better with standard treatments, by understanding how some cancer cells hide from the immune system and finding better ways to fight them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miami VA Health Care System NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project ID | NIH-11050121 on NIH RePORTER |
What this research studies
This research investigates a novel therapeutic strategy targeting the kynurenine pathway to treat lung cancer that is resistant to cisplatin and evades immune detection. The study focuses on understanding how certain cancer cells manipulate their environment to avoid immune responses, particularly through the activity of specific proteins like IDO1 and YAP1. By analyzing these mechanisms, the researchers aim to develop more effective treatments for patients with non-small cell lung cancer (NSCLC) who do not respond to existing therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer who have shown resistance to cisplatin-based therapies.
Not a fit: Patients with lung cancer that is sensitive to cisplatin or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with resistant lung cancer, potentially increasing survival rates.
How similar studies have performed: Previous research has shown promise in targeting immune evasion mechanisms in cancer, suggesting that this approach could be effective, although it is still considered novel.
Where this research is happening
Miami, United States
- Miami VA Health Care System — Miami, United States (Active)
Researchers
- Principal investigator: Wangpaichitr, Medhi — Miami VA Health Care System
- Study coordinator: Wangpaichitr, Medhi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.